腦出血管理指南

1、Guidelines for the Management of SpontaneousIntracerebral Hemorrhage(ICH),Purpose The aim of this guideline is to present current and comprehensive recommendations for the diagnosis and treatment of spontaneous ICH Methods A formal literature search of PubMed was performed from 2009 through 2013 Res

2、ults Evidence-based guidelines are presented for the care of patients with acute ICH Conclusions ICH remains a serious condition for which early aggressive care is warranted.These guidelines provide a framework for goal-directed treatment of the patient with ICH,Recommendations follow the American H

3、eart Association(AHA)/American Stroke Association(ASA)smethods of classifying the level of certainty of the treatment effect and the class of evidence,Emergency Diagnosis and Assessment,Recommendations,1. A baseline severity score should be performed as part of the initial evaluation of patients wit

4、h ICH (Class I;Level of Evidence B). (New recommendation) 2. Rapid neuroimaging with CT or MRI is recommended to distinguish ischemic stroke from ICH(Class I; Level of Evidence A). (Unchanged from the previous guideline) 3. CTA and contrast-enhanced CT may be considered to help identify patients at

5、risk for hematoma expansion (Class IIb; Level of Evidence B), CTA,CT venography, contrast-enhanced CT, contrastenhanced MRI, magnetic resonance angiography and magnetic resonance venography, and catheter angiography can be useful to evaluate for underlying structural lesions including vascular malfo

6、rmations and tumors when there is clinical or radiological suspicion(Class IIa; Level of Evidence B). (Unchanged from the previous guideline),Medical Treatment for ICH,Hemostasis and Coagulopathy, Antiplatelet Agents,and (deep vein thrombosis, DVT) Prophylaxis,Recommendations,1. Patients with a seve

7、re coagulation factor deficiency or severe thrombocytopenia should receive appropriate factor replacement therapy or platelets, respectively(Class I; Level of Evidence C). (Unchanged from the previous guideline) 2. The usefulness of platelet transfusions in ICH patients with a history of antiplatele

8、t use is uncertain (Class IIb; Level of Evidence C). (Revised from the previous guideline) 3. Patients with ICH whose (international normalized ratio,INR) is elevated because of (Vitamin K antagonists ,VKA) should have their VKA withheld, receive therapy to replace vitamin Kdependent factors and cor

9、rect the INR, and receive intravenous vitamin K (Class I; Level of Evidence C).,4. Patients with ICH should have intermittent pneumatic compression for prevention of venous thromboembolism beginning the day of hospital admission(Class I; Level of Evidence A). Graduated compression stockings are not

10、beneficial to reduce DVT or improve outcome (Class III; Level of Evidence A).(Revised from the previous guideline) 5. After documentation of cessation of bleeding, lowdose subcutaneous low-molecular-weight heparin or unfractionated heparin may be considered for prevention of venous thromboembolism i

11、n patients with lack of mobility after 1 to 4 days from onset (Class IIb; Level of Evidence B). (Unchanged from the previous guideline) 6. Systemic anticoagulation or (inferior vena cava,IVC) filter placement is probably indicated in ICH patients with symptomatic DVT or (pulmonary embolism, PE) (Cla

12、ss IIa; Level of Evidence C),BP and Outcome in ICH:Recommendations,1. For ICH patients presenting with SBP between 150 and 220 mmHg and without contraindication to acute BP treatment, acute lowering of SBP to 140 mmHg is safe (Class I; Level of Evidence A) and can be effective for improving function

13、al outcome (Class IIa; Level of Evidence B). (Revised from the previous guideline) 2. For ICH patients presenting with SBP 220 mmHg,it may be reasonable to consider aggressive reduction of BP with a continuous intravenous infusion and frequent BP monitoring (Class IIb; Level of Evidence C). (New rec

14、ommendation),General Monitoring and Nursing Care:Recommendation,Initial monitoring and management of ICH patients should take place in an intensive care unit or dedicated stroke unit with physician and nursing neuroscience acute care expertise (Class I; Level of Evidence B). (Revised from the previo

15、us guideline),Glucose Management: Recommendation,Glucose should be monitored. Both hyperglycemia and hypoglycemia should be avoided (ClassI; Level of Evidence C). (Revised from the previous guideline),Temperature Management: Recommendation,Treatment of fever after ICH may be reasonable (Class IIb; L

16、evel of Evidence C). (New recommendation),Seizures and Antiseizure Drugs:Recommendations,1. Clinical seizures should be treated with antiseizure drugs (Class I; Level of Evidence A). (Unchanged from the previous guideline) 2. Patients with a change in mental status who are found to have electrograph

17、ic seizures on (Electroencephalography,EEG) should be treated with antiseizure drugs (Class I;Level of Evidence C). (Unchanged from the previous guideline) 3. Continuous EEG monitoring is probably indicated in ICH patients with depressed mental status that is out of proportion to the degree of brain

18、 injury (Class IIa; Level of Evidence C). (Revised from the previous guideline) 4. Prophylactic antiseizure medication is not recommended (Class III; Level of Evidence B). (Unchanged from the previous guideline),Management of Medical Complications:Recommendations,1. A formal screening procedure for

19、dysphagia should be performed in all patients before the initiation of oral intake to reduce the risk of pneumonia (Class I;Level of Evidence B). (New recommendation) 2. Systematic screening for myocardial ischemia or infarction with electrocardiogram and cardiac enzyme testing after ICH is reasonab

20、le (Class IIa;Level of Evidence C). (New recommendation),(Intracranial pressure,ICP ) Monitoring and Treatment: Recommendations,1. Ventricular drainage as treatment for hydrocephalus is reasonable, especially in patients with decreased level of consciousness (Class IIa; Level of Evidence B). (Revise

21、d from the previous guideline) 2. Patients with a GCS score of 8, those with clinical evidence of transtentorial herniation, or those with significant (Intraventricular hemorrhage,IVH) or hydrocephalus might be considered for ICP monitoring and treatment.(Class IIb; Level of Evidence C). (Unchanged

22、from the previous guideline) 3. Corticosteroids should not be administered for treatment of elevated ICP in ICH (Class III; Level of Evidence B). (New recommendation),Surgical Treatment of ICH: Recommendations,1. Patients with cerebellar hemorrhage who are deteriorating neurologically or who have br

23、ainstem compression and/or hydrocephalus from ventricular obstruction should undergo surgical removal of the hemorrhage as soon as possible (Class I; Level of Evidence B). Initial treatment of these patients with ventricular drainage rather than surgical evacuation is not recommended (Class III; Lev

24、el of Evidence C).(Unchanged from the previous guideline) 2. For most patients with supratentorial ICH, the usefulness of surgery is not well established (Class IIb; Level of Evidence A). (Revised from the previous guideline) Specific exceptions and potential subgroup considerations are outlined bel

25、ow in recommendations3 through 6,3. A policy of early hematoma evacuation is not clearly beneficial compared with hematoma evacuation when patients deteriorate (Class IIb; Level of Evidence A). (New recommendation) 4. Supratentorial hematoma evacuation in deteriorating patients might be considered a

26、s a life-saving measure (Class IIb; Level of Evidence C). (New recommendation) 5. hematoma evacuation might reduce mortality for patients with supratentorial ICH who are in a coma, have large hematomas with significant midline shift, or have elevated ICP refractory to medical management (Class IIb;

27、Level of Evidence C). (New recommendation) 6. The effectiveness of minimally invasive clot evacuation with stereotactic or endoscopic aspiration is uncertain (Class IIb; Level of Evidence B). (Revised from the previous guideline),Prevention of Recurrent ICH: Recommendations,1. BP should be controlle

28、d in all ICH patients (Class I; Level of Evidence A). (Revised from the previous guideline) Measures to control BP should begin immediately after ICH onset (Class I; Level of Evidence A). (New recommendation) A long-term goal of BP 130 mm Hg systolic and 80 mmHg diastolic is reasonable (Class IIa; L

29、evel of Evidence B). (New recommendation) 2. Lifestyle modifications, including avoidance of alcohol use greater than 2 drinks per day, tobacco use,and illicit drug use, as well as treatment of obstructive sleep apnea, are probably beneficial (Class IIa;Level of Evidence B). (Revised from previous guideline) 3. Avoidance of long-term anticoagulation with warfarin as a treatment for nonvalvular atrial fibrillation is probably recommended after warfarin-assoc